Evaluating the Benefits and Adverse Effects of an Enthracycline-Taxane-Capecitabine Combined Regimen in Patients With Early Breast Cancer

Oncotarget - United States
doi 10.18632/oncotarget.20386
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Accelerated Whole Breast Irradiation in Early Breast Cancer Patients With Adverse Prognostic Features

Oncotarget
Oncology
2016English

Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer

JAMA Oncology
Cancer ResearchOncology
2015English

Q-TWiST Analysis of Lapatinib Combined With Capecitabine for the Treatment of Metastatic Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2008English

Evolving Approaches to Metastatic Breast Cancer Patients Pre-Treated With Anthracycline and Taxane

BioDrugs
MedicineBiotechnologyPharmacology
2013English

Phase II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer

The Internet Journal of Oncology
2007English

CREATE-X a Role for Capecitabine in Early-Stage Breast Cancer: An Analysis of Available Data

npj Breast Cancer
OncologyRadiologyNuclear MedicinePharmacologyImaging
2017English

Symptoms Experience and Quality of Life in the Patients With Breast Cancer Receiving the Taxane Class of Drugs

European Journal of Breast Health
2018English

Weekly Taxane–anthracycline Combination Regimen Versus Tri-Weekly Anthracycline-Based Regimen for the Treatment of Locally Advanced Breast Cancer: A Randomized Controlled Trial

Chinese Journal of Cancer
2017English

Phase II, Multicenter, Single-Arm, Feasibility Study of Eribulin Combined With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive, Early-Stage Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy